|Day Low/High||358.06 / 364.31|
|52 Wk Low/High||258.10 / 459.75|
Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, January 31, 2019, the company will release financial results for the third quarter of fiscal 2019.
Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R.
In the daily bar chart of Abiomed we can see a number of bearish signals.
Jim Cramer weighs in on Hormel, Medtronic, Cisco and more.
Jim Cramer says the market pain will eventually end, once the Fed sees the error of its ways.
Abiomed (NASDAQ: ABMD) announces the results of the FDA STEMI Door-to-Unloading safety and feasibility randomized controlled trial, which show unloading the left ventricle with Impella CP ® for 30 minutes prior to reperfusion in patients presenting with...
Jim Cramer is concerned about risk, and the Fed. But, he says, you need to get in there and talk with the CEOs to get the real story about the economy.
Jim Cramer takes a closer look at Express Scripts, Lockheed Martin, Raytheon, Abiomed.
Let's check out the charts and indicators.
Big-cap FAANG names and Apple, in particular, were the beneficiaries.
Jim Cramer takes a closer look at Children's Place, Abiomed, Barrick Gold, Dynavax Technologies, Zebra Technologies, Chesapeake Energy.
Jim Cramer says this market is all about being opportunistic, about being willing to fight the tide.
Investors have fallen in love with 10 stocks this year despite their heady valuations. Talk about dangerous.
Jim Cramer weighs in on Automatic Data Processing, ADT, Discovery Communications, Abiomed, L Brands and more.
Markets look calm, but we're seeing some extraordinary breakouts, says Jim Cramer.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.